| Altretamine |
50 mg |
Capsules |
|
| Bendamustine Hydrochloride |
25mg in 8 mL, 100mg in 20 mL |
Injection |
Y43.3 |
| Busulphan |
solution in 10 mL |
Injection |
|
| Carboplatin |
50 mg/5 mL, 150 mg/15 mL, 450 mg/45 mL, 600 mg/60 mL |
Injection |
|
| Carmustine |
vial containing 100 mg |
Injection |
Y43.3 |
| Chlorambucil |
2 mg |
Tablets |
|
| Cisplatin |
1 mg/mL; 200 mg/200 mL |
Injection |
|
| Cyclophosphamide |
500 mg vial, carton of 1, 1.0 g vial, carton of 1, .2.0 g vial, carton of 1 |
Injection |
|
| Dacarbazine |
100 mg, 200 mg/20ml, 500 mg |
Injection |
|
| Ifosfamide |
500 mg , 1-gram, 3-gram, Single-Dose Vial
|
Injection |
|
| Lomustine |
10mg, 40mg, 100mg |
Capsule |
|
| Mechlorethamine |
10 mg |
Injection |
Y43.3 |
| Melphalan |
2 mg film-coated |
Tablets |
|
| Oxaliplatin |
50 mg, 100 mg or 200 mg Vials |
Injection |
|
| Procarbazine |
50 mg |
Capsules |
|
| Streptozocin |
1 gram vials |
Sterile Powder |
|
| Temozolomide |
5 mg, 20mg, 100mg, 140mg, 180mg, 250mg |
Capsules |
|
| Thiotepa |
15 mg , sterile lyophilized powder |
Injection |
|
Antimetabolites
| Generic Name(s) |
Strength |
Dosage Form |
ICD Code |
| Azacitidine |
100mg single-use vials. |
Injection |
Y43.1 |
| Capecitabine |
150mg, 500mg |
Tablets |
|
| Cladribine |
10 mg (1 mg/mL) |
Injection |
Y43.3 |
| Clofarabine |
20mg/20 mL |
Injection |
Y43.3 |
| Cytarabine |
100 mg, 500 mg, 1 g, 2 g |
Injection |
|
| Decitabine |
50mg/Vial |
Injection |
Y43.3 |
| Floxuridine |
500 mg/vial |
Injection |
|
| Fludarabine |
50 mg |
Injection |
|
| Fluorouracil |
30 gram tube |
0.5% Cream |
|
| Gemcitabine |
200 mg, 1 g white to off-white, lyophilized powder |
Injection |
|
| Hydroxyurea |
500 mg |
Capsules |
|
| Mercaptopurine |
50 mg |
Tablets |
|
| Methotrexate |
5mg, 7.5mg, 10mg, 15mg |
Tablets |
|
| Nelarabine |
250 mg/50 mL (5 mg/mL) vial |
Injection |
|
| Pemetrexed |
100mg/1vial, 500mg/1vial |
Injection |
|
| Pentostatin |
50 mg |
Injection |
|
| Pralatrexate Solution |
20mg / 1mL, 40mg / 2mL |
Injection |
|
| Thioguanine |
40 mg |
Tablets |
|
Antitumor Antibiotics
| Generic Name(s) |
Strength |
Dosage Form |
ICD Code |
| Aclarubicin |
25 to 100 mg/m2 |
Injection |
Y43.3 |
| Bleomycin |
15, 30 units per vial |
Injection |
|
| Dactinomycin |
0.5 mg x 1's |
Injection |
|
| Daunorubicin |
20 mg, single dose vials; carton of 10. |
Injection |
|
| Doxorubicin |
10mg, 20mg, 50mg, 150mg , single dose vial |
Injection |
|
| Epirubicin |
50 mg/25 mL, 200 mg/100 mL single-use vial |
Injection |
|
| Idarubicin |
20 mg single dose vial |
Injection, |
|
| Mitomycin |
5mg, 20mg, 40mg |
Injection |
|
| Mitoxantrone |
20 mg/10 mL/multidose vial |
Injection |
|
| Plicamycin |
2500 mcg/Vial |
Injection |
|
Cytoprotective agent
| Generic Name(s) |
Strength |
Dosage Form |
ICD Code |
| Mesna |
400mg, 100mg/ml vial |
Tablet, Injection |
|
Hormonal Therapy
| Generic Name(s) |
Strength |
Dosage Form |
ICD Code |
| Abarelix |
50 mg/mL |
Injection |
Y43.3 |
| Abiraterone acetate |
250 mg |
Tablet |
Y43.3 |
| Buserelin |
200-500 mcg/day |
Injection |
Y43.3 |
| Diethylstilbestrol |
10-20 mg/day |
Tablet, injection |
Y43.3 |
Isocitrate dehydrogenase-2 (IDH2) inhibitor
| Generic Name(s) |
Strength |
Dosage Form |
ICD Code |
| Enasidenib |
50 mg, 100 mg |
Tablet |
|
Kinase Inhibitor
| Generic Name(s) |
Strength |
Dosage Form |
ICD Code |
| Binimetinib |
15 mg |
Tablet |
|
| Encorafenib |
50 mg, 75 mg |
Capsule |
|
| Erlotinib |
25mg, 100mg, 150mg, |
Tablets, Oral |
Y43.3 |
| Ribociclib |
200mg |
Tablet |
|
Miscellaneous Antineoplastics
| Generic Name(s) |
Strength |
Dosage Form |
ICD Code |
| Aldesleukin |
22 million units |
Injection |
Y43.3 |
| Asparaginase |
10, 000 International Units as lyophilized powder |
Injection |
|
| Bexarotene |
75-mg |
Capsules |
Y43.3 |
| Brentuximab Vedotin |
50mg/Vial |
Injection |
Y43.3 |
| Cabazitaxel |
60mg/1.5 mL |
Injection |
Y43.3 |
| Denileukin Diftitox |
2ml/Vial |
Injection |
Y43.3 |
| Eribulin Mesylate |
1 mg/2mL (0.5 mg/mL)/ vial. |
Injection |
Y43.3 |
| Estramustine |
140 mg |
Capsules |
|
| Exemestane |
25mg |
Tablets |
Y43.3 |
| Gefitinib |
250mg |
Tablets |
Y43.3 |
| Interferon Alfa 2A |
3 million IU, 6 million IU , 9 million IU/0.5ml |
Injection |
Y43.3 |
| Interferon Alfa-N3 -Human Leukocyte Derived |
0.05 ml to 0.5ml |
Injection |
Y43.3 |
| Interferon Beta 1A |
30mcg/Vial |
Injection |
Y43.3 |
| Interferon Beta-1B |
0.3mg/vial |
Injection |
|
| Interferon Gamma 1B |
100 mcg (2 million lU) |
Injection |
Y43.3 |
| Isotretinoin |
10mg, 20mg, 40mg |
Capsules |
|
| Ixabepilone |
15mg/8ml |
Injection |
Y43.3 |
| Lapatinib |
250mg |
Tablets |
Y43.3 |
| Letrozole |
2.5mg |
Tablets |
Y43.3 |
| Mitotane |
500 mg |
Tablets |
|
| Niraparib |
100mg |
Capsule |
|
| Pegaspargase |
3,750 IU/5 mL single-use vial |
Injection |
|
| Tretinoin (ATRA) |
45 g tubes |
Gel, 0.05% |
|
Monoclonal antibody
| Generic Name(s) |
Strength |
Dosage Form |
ICD Code |
| Alemtuzumab |
30 mg/1ml |
Injection |
Y43.3 |
| Bevacizumab |
25mg x 1 mL x 4ml |
Injection |
Y43.3 |
| Gemtuzumab |
5mg/vial |
Injection |
Y43.3 |
| Ibritumomab Tiuxetan |
3.2mg/2ml |
Injection |
Y43.3 |
Plant alkaloids
| Generic Name(s) |
Strength |
Dosage Form |
ICD Code |
| Docetaxel |
20 mg, 80 mg, Lyophilized Powder |
Injection |
|
| Etoposide |
45-50 mg pink capsules |
Capsules |
|
| Paclitaxel |
30 mg/5 mL, 100 mg/16.7 mL, 300 mg/50 mL, multidose vial |
Injection |
|
| Teniposide |
165 mg/m2 |
Injection |
|
| Vinblastine |
10 mg |
Injection |
|
| Vincristine |
1 mg/1 mL (single dose), 2 mg/2 mL (single dose) |
Injection |
|
| Vinorelbine Tartrate |
10 mg/1 mL Single-Use Vial, Carton of 1, 50 mg/5 mL Single-Use Vial, Carton of 1 |
Injection |
|
Proteasome Inhibitor
| Generic Name(s) |
Strength |
Dosage Form |
ICD Code |
| Bortezomib |
3.5mg/10ml |
Injection |
Y43.3 |
Topoisomerase inhibitors
| Generic Name(s) |
Strength |
Dosage Form |
ICD Code |
| Amsacrine |
90 to 120 mg/m2 |
Injection |
|
| Irinotecan |
2ml, 5ml |
Injection |
|
| Topotecan |
0.25mg, 1mg |
Capsules |
|